No profile data available.
Allarity Therapeutics, Inc. (ALLR) is a healthcare company in the additional cancer treatment drugs industry, based in Tarpon Springs, United States, with about 7 full-time employees.
It reported revenue of $320,000 for fiscal year 2025, and net income of -$11.23 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $15.75 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States.
Allarity Therapeutics reported $320,000 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$15.75 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Akari Therapeutics, Plc (AKTX), Curis, Inc. (CRIS), Abpro Holdings, Inc. (ABP), Pasithea Therapeutics Corp. (KTTA).